Skip to content

Phillip Blake Dauwe, M.D.

NPI 1699090431ActiveIndividual· Plastic Surgery· Dallas, TX

Plastic Surgery (M.D.) in Dallas, Texas, licensed in TX and CA, with an NPI issued in April 2010. Part D covered 69 prescriptions written in 2024, 97% of them generic. Revance Therapeutics, Inc. was the largest of 5 companies reporting payments in 2025, $1,238 in all, mostly food and beverage.

Overview

NPI1699090431
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedApr 5, 2010
Last updated in NPPESMay 1, 2017

Specialties and licenses

TaxonomyCodeLicenseState
Plastic Surgery Primary208200000XQ4744TX
Plastic Surgery208200000XA138672CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)69 · 69 30-day fills
Patients24
Total drug cost$706.78
Generic share97% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,238 · 46 payments from 5 companies
  • 2024$1,184 · 47 payments from 5 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$1,238 · 46 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other plastic surgeons in Dallas

All 92 plastic surgeons in Dallas · All plastic surgeons in Texas